Sunday, November 27, 2022
Home Tags BI

Tag: BI

Exclusive: Boehringer Ingelheim USA President/CEO Jean-Michel Boers on firm’s 50th anniversary,...

“The speed at which the industry was able to offer highly efficacious vaccinations is quite extraordinary,” Boers marvels. “It shows how important it is to invest in health care in the U.S.”

Boehringer Ingelheim appoints Yew Looi Liew as U.S. Human Pharma president

Liew, who succeeds Jean-Michel Boers, will be responsible for developing BI’s current human pharma portfolio and preparing the organization for future launches.

Boehringer Ingelheim and FDA ramp up anti-counterfeit medicine efforts

The pair's “Know Your Source” initiative is the latest step in an international fight against a black market estimated at $200 billion.

Smart decisions, codified by Decisyon

New platform from Decisyon wrangles big data and promises customer satisfaction.